glp-1 affordability Affordable weight loss options at Forest Heights Pharmacy How to Afford GLP-1s in

Stachyose in combination with L

FOXO4-DRI vs nearby senolytics Option FOXO4-DRI Type D-retro-inverso peptide Human trial stage None (preclinical only) Option Dasatinib + Quercetin (D+Q) Type Small-molecule drug + flavonoid Human trial stage Early human trials (e.g., Alzheimer's) Option Navitoclax Type BCL-2 family inhibitor Human trial stage Later-stage trials (e.g., myelofibrosis) D+Q and navitoclax are further along in humans but can affect healthy cells (e.g., low platelets)

Betts, S

MAO-B inhibitors and catechol- O -methyl-transferase inhibitors attenuate motor fluctuations in carbidopa/L-dopatreated patients

Discard any vial that is cloudy, discoloured or contains particles rather than risk using it

number needed to treat = 121) 13% reduction in cardiovascular death (IRR 0.87